[New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
The Authors have studied the haematic levels of CA 125, CA 19-9, CA 50, CEA, and TPA in 23 women with ovarian cancer and in 14 healthy women. The results showed as the simultaneous use of CA 125 and TPA can premise the diagnosis of ovarian cancer in high percentage.
Indraccolo
S R
SR
Scuola Autonoma di Ostetricia di Camerino, Università degli Studi di Roma La Sapienza.
Cecchi
A
A
Thodos
A
A
Brandi
S
S
Carta
G
G
D000951:Antigens, Neoplasm / Q000032:analysis; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000276:immunology; D010455:Peptides / Q000032:analysis; D011863:Radioimmunoassay; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen
Nuove prospettive nell'utilizzo combinato dei marcatori tumorali nelle neoplasie epiteliali dell'ovaio.